Physical Performance of Women at Different Stages of the Menstrual Cycle, and Photobiomodulation Therapy
Menstrual Cycle Disorder
About this trial
This is an interventional treatment trial for Menstrual Cycle Disorder focused on measuring Menstrual cycle, Photobiomodulation therapy, Fatigue, Clinical Trial
Eligibility Criteria
Inclusion Criteria:
- Women
- 18 to 35 years
- Healthy
- Physically Active (150 min / week)
Exclusion Criteria:
- Eating disorders;
- Hormonal disorders;
- Amenorrhea;
- Pregnancy;
- Polycystic ovary;
- Endometriosis;
- Tumors;
- Musculoskeletal injury in the last 6 months;
- Cardiorespiratory disease;
- Use of alcohol and illegal drugs during the study.
Sites / Locations
- Rinaldo Roberto de Jesus Guirro
- Universidade de São Paulo
Arms of the Study
Arm 1
Arm 2
Experimental
Sham Comparator
G-FBM-CEN
G - Sham - CEN
Photobiomodulation application in women of endogenous cycle. Antares® equipment (IBRAMED, Amparo-SP, Brazil) will be used, by means of a cluster, with two wavelengths (13 LEDs of 630 nm, 300 mW + 13 LEDs of 850 nm, 500 mW), being its area of 80 cm² contact, acting 180 J of energy being applied at 15 points on each thigh - 9 in the anterior region and 6 in the posterior region, in addition to 2 points in the gastrocnemius.
Sham Photobiomodulation (disabled) application in women of endogenous cycle. The procedure and equipment will be the same as for the experimental groups, however no dosage will be applied: Antares® equipment (IBRAMED, Amparo-SP, Brazil) will be used, by means of a cluster, with two wavelengths (13 LEDs of 630 nm, 300 mW + 13 LEDs of 850 nm, 500 mW), being its area of 80 cm² contact, with 0 J of energy being applied at 15 points on each thigh - 9 in the anterior region and 6 in the posterior region, in addition to 2 points in the gastrocnemius.